Objectives: Since a relation between trans-fatty acids and cardiovascular diseases has been described, we examined the relationship between margarine intake and nonfatal acute myocardial infarction (AMI) in Italian women. Design: Hospital-based case-control study. Setting: Northern Italy between 1983 and 1992. Subjects: Cases were 429 women, aged 18-74 y, in hospital with diagnosis of AMI and 866 controls in hospital for acute, non-cardiovascular, non-neoplastic, non-digestive, non-hormone-related conditions. Analysis: Odds ratios (OR), with their 95% confidence intervals (CI), were computed by unconditional multiple logistic regression analysis, including terms for age, education, body mass index, smoking, alcohol and coffee drinking, menopausal status, hormone replacement therapy and history of diabetes, hypertension and hyperlipidemia. Results: Medium or high intake of margarine was associated with an increased risk of AMI (multivariate OR 1.5, 95% CI 1.0-2.2). Analysis in separate strata of covariates indicated that the association was independent of body mass index, history of hypertension and hyperlipidemia, and was greater in older women and in current smokers. Conclusions: If real, the association with margarine could explain about 6% of AMI in this population of Italian women. Sponsorship: This work was conducted within the contribution of the Italian League against Cancer, Milan.
Introduction
Trans-fatty acids occur naturally in small amounts in meats and dairy products and in variable amounts in commercially prepared, partially hydrogenated fats, mainly margarines (Introduction, 1995; Emken, 1995) . Given the broad public health relevance of the issue, a possible relation between trans-fatty acids and risk of cardiovascular disease is of lively interest (Willett and Ascherio, 1994, 1995; Allison, 1995; Katan, 1995a,b) , arousing widely diverging opinions (Allison, 1995; Katan, 1995a) .
Epidemiological evidence based on a few case-control and prospective studies showed controversial results. Two case-control studies, one conducted in Greece (Tzonou et al, 1993) and one in the United States , and two American cohorts (Willett et al, 1993; Gillman et al, 1995) suggested that a high intake of trans-fatty acids and/or margarine was associated with an increased risk of cardiovascular disease and acute myocardial infarction (AMI). In the American Nurses Health Study (Willett et al, 1993) , the multivariate relative risks in subsequent quintiles of total trans-fatty acid intake were 1.2, 1.1, 1.4 and 1.7 with a linear trend in risk, and in a case-control study from the Boston area the odds ratios (OR) were 0.8, 0.4, 0.7 and 2.0 .
These results, however, were not confirmed by two other cohort studies, one conducted in Finnish men and women (Knekt et al, 1994) and the other in American postmenopausal women (Kushi et al, 1996) , which found no association between margarine intake and coronary heart disease incidence and mortality respectively, and by a case-control study (Roberts et al, 1995) , which found no relationship between trans-fatty acid levels in adipose tissue and sudden cardiac death in 66 British men (OR of 0.4 for the highest quintile of intake). Another case-control study (Aro et al, 1995) found no relationship between trans-fatty acid in adipose tissue and AMI in men from different European countries and Israel, although after the exclusion of two Spanish centres the OR arouse from 0.97 to 1.44.
Biochemical evidence is based on the observation that trans-fatty acid intake may adversely affect serum lipoprotein profile (Mensink and Katan, 1990; Siguel and Lerman, 1993; Wood et al, 1993; Zock and Katan, 1995) . Increases in low-density lipoprotein (LDL) and decreases in highdensity lipoprotein (HDL) serum levels have also been reported, although the changes were moderate and, because of small numbers, not significant in a few studies. Still the ratio of total to HDL cholesterol was directly related to the percentage of energy obtained from trans-fatty acids in a systematic review of six studies (Willett and Ascherio, 1995) .
This epidemiological and biochemical data had major implications for margarine composition and labelling in the Correspondence: Dr A Tavani. Received 22 May 1996; revised 16 September 1996; accepted 27 September 1996 Netherlands, where some manufacturers reduced the transfatty acid content to less than 5%, and reported it on their labels (Katan, 1995b) . It is therefore important to analyse the relationship between cardiovascular diseases and trans-fatty acid intake in different populations. To provide further information on this issue, we studied the relationship between nonfatal AMI and margarine intake, analysing the data of a large case-control study of Italian women.
Subjects and methods
Data were derived from a case-control study of AMI, conducted in women in northern Italy since 1983. Originally, the study focused on oral contraceptives and other hormonal factors, and hence had an upper age limit of 54 y. This limit was raised to 74 y in 1987, and the present analysis is based on data collected until December 1992.
The general design and methods of this investigation have already been described (La Vecchia et al, 1987; Gramenzi et al, 1990) . Cases were 429 women (median age 53 y, range 18-74) with a first episode of nonfatal AMI, admitted to 30 coronary care units in Northern Italy. Controls were 866 women (median age 52 y, range 18-74) admitted to the same network of hospitals where cases were identified, for acute diseases other than cardiovascular, neoplastic, digestive and hormone-related conditions, or any disease associated with long-term changes to the diet. Of these, 31% were admitted for traumatic conditions; 33% had non-traumatic orthopedic disorders (mainly low back pain and disc diseases); 14% had acute surgical conditions (such as acute appendicitis or strangulated hernia), and 22% had other miscellaneous illnesses (such as acute infections, ear, nose and throat, eye, dental or skin disorders). On average, less than 5% of the eligible cases and controls refused to be interviewed.
Trained interviewers used a structured questionnaire to collect data on socio-demographic characteristics, selfreported anthropometric measures, smoking habits, intake of alcohol, coffee and a few selected indicator foods, gynecological and obstetric history, hormonal therapy, history of diabetes, hypertension, hyperlipidemia and other selected medical conditions, personal and family history of cardiovascular diseases. Information on diet was specifically related to the period before the onset of symptoms of the disease which led to hospital admission and included frequencies of consumption of 14 selected indicator foods, including a subjective score of the margarine, butter and oil intake (no or low/medium or high). Cases and controls were interviewed in a hospital setting.
Data analysis
Odds ratios (OR), as estimators of relative risks of AMI, together with the corresponding 95% confidence intervals (CI), were computed in relation to margarine intake using unconditional multiple logistic regression, fitted by the method of maximum likelihood, to allow for several possible confounding factors (Breslow and Day, 1980) . Logistic regression models included terms for quinquennia of age (11 levels), education (< 5/ 5 y), body mass index (tertiles), smoking habits (never/current/ex-smokers), alcohol drinking (nondrinkers/> 0-2/> 2 drinks per day), coffee drinking ( < 2/2-3/ > 3 cups per day), menopausal status (pre-and peri-/post-menopause), hormone replacement therapy (never/ever) and history of diabetes (no/yes), hypertension (no/yes) and hyperlipidemia (no/yes).
Results
The relationship between risk of nonfatal AMI and margarine intake is shown in Table 1 . Compared to no or low intake of margarine, a medium or high intake increased the risk of AMI, with an OR of 1.4 (95% CI 1.0-1.9) after adjustment for age only, and of 1.5 (95% CI 1.0-2.2) in the multivariate analysis; the risk estimate was not affected by further allowance for intake of oil and butter for seasoning.
The association was apparently stronger in women aged 60-74 y (OR 2.4), in those with more than five year of education (OR 1.8) and in current smokers (OR 2.3). Conversely, no difference was observed across strata of body mass index (OR 1.5 and 1.6 respectively for below and above the median value, 24.25 kg/m 2 ), and history of hypertension (OR 1.5 and 1.6) and hyperlipidemia (OR 1.5 and 1.9). No interaction was observed between margarine intake, age and smoking status.
Discussion
The results of this study provide support for a role of margarine in the etiology of nonfatal AMI in women. The strength of the association was apparently greater in older 
women and in current smokers, in the absence of significant interaction with any of the covariates considered. A major limitation of this study was the low intake of margarine by these Italian women, which reduced the statistical power and did not allow us to examine the trend in risk across several consumption levels. Moreover, the questionnaire was not validated, and we had no information on fats in pre-cooked foods, which however, are not commonly used in Italy. With relation to their composition, margarines are an important source of trans-fatty acids in Italian diet, whose content, however, varies in the different commercially available brands. Italian margarines are mainly derived by corn and grape seed oils and, more recently, by sunflower seed oil, and synthetic antioxidants are not allowed. Another potential limitation of this study regards the choice of hospital controls, since they may differ from the general population in several aspects. However, any such bias should be limited, because we specifically excluded from the comparison group any disease potentially inducing long-term changes in the diet, as well as any other chronic and metabolic condition. As for other potential sources of bias, the interviews were conducted in the same setting for cases and controls (during hospital stay), the participation rate was practically complete, cases and controls were drawn from the same catchment areas, and the hospital setting should improve the comparability of recall between cases and controls (Mantel and Haenszel, 1959; D'Avanzo et al, 1996) . Moreover, it is not likely that margarine consumption is associated with other characteristics of diet that relate to AMI risk, as margarine usually take the place of butter, thus reducing the intake of saturated fatty acids.
With relation to confounding, allowance was made for major identified potential distorting factors, including use of butter and oil (the fat used most for seasoning in Italy) and no significant change in risk estimates was observed. Moreover, the potential association of margarine consumption with hyperlipidemia, hypertension and diabetes should not materially influence the risk estimates, as the OR adjusted for age only (1.4) resulted indeed lower than the multivariate estimate (1.5). This indicates that even more accurate allowance is unlikely to explain the association observed.
A possible biological mechanism underlying the positive association of AMI with margarine intake is its influence on the lipoprotein profile. In fact, most commercial margarines have a high content of trans-fatty acids (Introduction, 1995; Emken, 1995) , which adversely affect the serum lipoprotein profile, raising not only total cholesterol, but also the low-density lipoproteins, and reducing high-density lipoproteins (Mensink and Katan, 1990; Siguel and Lerman, 1993; Wood et al, 1993; Zock and Katan, 1995) .
As cardiovascular disease is one of the leading causes of death in developed countries and as margarine use is widespread in many of these countries, even a small increase in risk may be relevant on a public health scale. In our population, the attributable risk (Mezzetti et al, 1996) was about 6%. However, as indicated by the Dutch experience (Katan, 1995b) , intervention on trans-fatty acids composition of margarines is not only possible, but advisable.
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